China accuses former GSK head of bribing doctors
Updated: 2014-05-14 15:39
According to police, Reilly and his colleagues disguised illegal revenue in the Chinese market by forging transactions between GSK China and several foreign arms of GSK, making the revenue look like funds used to purchase raw materials in China. They made every effort to cover up the illegal practice during regular checks by regulatory authorities. In terms of sales of prescription drugs and vaccines, police found that all pharmaceutical factories and departments of GSK China nationwide had been involved in commercial bribery.
Last July, police detained four senior executives of GSK China on suspicion of commercial bribery. Reilly was not among them.
- China hosts major Asia security conference
- Xi vows support for Afghanistan reconstruction
- Security summit to help build mutual trust
- Russian president arrives for state visit
- China suspends cyber working group activities with US to protest cyber theft indictment
- China publishes latest data of US cyber attack